As China's memory-chip giants YMTC and CXMT progress towards IPOs, they shine a spotlight on Beijing's tech self-sufficiency ...

ChangXin Memory Technologies is sparking investor interest as DRAM profits soar, AI drives shortages and China pushes for ...

Anticipation is building for a potential OpenAI IPO. Discover the latest valuation trends and risks before the ChatGPT maker ...

On 27 April 2026, the Financial Conduct Authority (FCA) published Consultation Paper 26/14: Changes to Information Flows for UK Equity IPOs, which proposes changes to the rules governing the ...

Lincoln International, Inc. (LCLN) has filed to raise funds from an IPO of its Class A common stock, according to an S-1 registration statement. The company provides a full range of investment banking ...

Geothermal startup Fervo Energy said Monday it hopes to raise up to $1.3 billion in its initial public offering. The company would be valued at up to $6.5 billion if shares sell at the top of its $21 ...

Most investors won't be able to get in ahead of Jersey Mike's planned IPO. The best alternative is to buy shares of Blackstone, which owns a majority stake in Jersey Mike's. Wall Street is hungry for ...

Missile Solutions unit produces propulsion systems for Patriot, THAAD, Tomahawk, Standard Missile Annual growth rates for new missile business expected in mid- to high-teens, CEO Kubasik said Kenneth ...

May 21 (Reuters) - SpaceX's IPO filing finally revealed the finances behind a company aiming to dominate industries ranging from rockets and satellites to AI and data centers. Led by billionaire CEO ...

SpaceX’s plan to go public will reportedly give CEO Elon Musk “virtually unchecked executive authority” and limit the rights of shareholders to sue the company. The plan, reported by Reuters today, ...

The U.S. IPO market has a new company problem–especially with smaller players. The number of publicly listed companies peaked at around 8,000 in 1996 and has since fallen by nearly half. While larger ...

Avalyn Pharma has overshot its expectations with a $300 million IPO that the biotech will use to fund late-stage studies of its inhaled versions of approved respiratory drugs. The company is offering ...